Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss
出版年份 2019 全文链接
标题
Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 20, Issue 9, Pages 1123-1134
出版商
Informa UK Limited
发表日期
2019-04-09
DOI
10.1080/14656566.2019.1594772
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and meta-analysis
- (2018) Andreas Fontalis et al. Expert Opinion On Drug Safety
- ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
- (2018) Henry G Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Tissue selective estrogen complex (TSEC)
- (2018) James H. Pickar et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Anabolic agents: what is beyond osteoporosis?
- (2018) Y. Liu et al. OSTEOPOROSIS INTERNATIONAL
- Inhibition of Aortic Valve Calcification by Local Delivery of Zoledronic Acid—an Experimental Study
- (2018) Andreas Synetos et al. Journal of Cardiovascular Translational Research
- Atherosclerotic Calcification: Wnt Is the Hint
- (2018) Isabella Albanese et al. Journal of the American Heart Association
- Regulation of Bone Metabolism by microRNAs
- (2018) Hanna Taipaleenmäki Current Osteoporosis Reports
- The bone remodelling cycle
- (2018) JS Kenkre et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Novel therapies in osteoporosis: PTH-related peptide analogues and inhibitors of sclerostin
- (2018) Tilman D Rachner et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass
- (2017) Tony M Keaveny et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
- (2017) Panagiotis Anagnostis et al. MATURITAS
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using GWAS to identify novel therapeutic targets for osteoporosis
- (2017) Olivia L. Sabik et al. Translational Research
- Profile of romosozumab and its potential in the management of osteoporosis
- (2017) Sian Yik Lim et al. Drug Design Development and Therapy
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy
- (2017) Benjamin Z. Leder Current Osteoporosis Reports
- Novel advances in the treatment of osteoporosis
- (2016) Christopher K. Y. Chan et al. BRITISH MEDICAL BULLETIN
- Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling
- (2016) Gary Hattersley et al. ENDOCRINOLOGY
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sex steroid deficiency–associated bone loss is microbiota dependent and prevented by probiotics
- (2016) Jau-Yi Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses
- (2016) J. Zhou et al. OSTEOPOROSIS INTERNATIONAL
- Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program
- (2015) Alexandra Papaioannou et al. CURRENT MEDICAL RESEARCH AND OPINION
- Denosumab for the treatment of osteoporosis
- (2015) Sarah Zaheer et al. Expert Opinion on Drug Metabolism & Toxicology
- A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
- (2015) Robert R. Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Risks and Benefits of Bisphosphonate Therapies
- (2015) Carlen Reyes et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis
- (2015) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sclerostin and DKK1: new players in renal bone and vascular disease
- (2015) Pieter Evenepoel et al. KIDNEY INTERNATIONAL
- A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis
- (2015) Santiago Palacios et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- The support of human genetic evidence for approved drug indications
- (2015) Matthew R Nelson et al. NATURE GENETICS
- Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports
- (2015) B. Aubry-Rozier et al. OSTEOPOROSIS INTERNATIONAL
- Multiple clinical vertebral fractures following denosumab discontinuation
- (2015) A. D. Anastasilakis et al. OSTEOPOROSIS INTERNATIONAL
- Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
- (2015) A. W. Popp et al. OSTEOPOROSIS INTERNATIONAL
- Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
- (2015) L. Karlsson et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
- (2015) Dae Hyun Kim et al. PLoS One
- SAT0479 Early Findings from Prolia® Post-Marketing Safety Surveillance for Atypical Femoral Fracture, Osteonecrosis of the Jaw, Severe Symptomatic Hypocalcemia, and Anaphylaxis
- (2014) M. Geller et al. ANNALS OF THE RHEUMATIC DISEASES
- Catheter based inhibition of arterial calcification by bisphosphonates in an experimental atherosclerotic rabbit animal model
- (2014) Andreas Synetos et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Osteoporosis Treatment Gap
- (2014) John A Kanis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011
- (2014) Daniel H Solomon et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Time Course of Bone Mineral Density Changes With Denosumab Compared With Other Drugs in Postmenopausal Osteoporosis: A Dose-Response–Based Meta-Analysis
- (2014) Jaap W. Mandema et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinician’s Guide to Prevention and Treatment of Osteoporosis
- (2014) F. Cosman et al. OSTEOPOROSIS INTERNATIONAL
- Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?
- (2014) R. Sapir-Koren et al. OSTEOPOROSIS INTERNATIONAL
- Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
- (2014) S. L. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review
- (2013) Erik F. Eriksen et al. BONE
- Skeletal Effects of Primary Hyperparathyroidism: Bone Mineral Density and Fracture Risk
- (2013) E. Michael Lewiecki et al. JOURNAL OF CLINICAL DENSITOMETRY
- Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study
- (2013) Desmond Padhi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013
- (2013) J. Compston et al. MATURITAS
- Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis
- (2013) S.-H. Lee et al. OSTEOPOROSIS INTERNATIONAL
- Osteoclasts: New Insights
- (2013) Feng Xu et al. Bone Research
- The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: Implications for the treatment and prevention of osteoporosis
- (2012) Erik R. Nelson et al. BONE
- Benefits and Risks of Bisphosphonate Therapy for Osteoporosis
- (2012) Sundeep Khosla et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis
- (2011) Liviawati Sutjandra et al. CLINICAL PHARMACOKINETICS
- Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
- (2011) Asiri R. Wijenayaka et al. PLoS One
- Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis
- (2010) Santiago Palacios CURRENT MEDICAL RESEARCH AND OPINION
- Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Long-Term Use of Bisphosphonates in Osteoporosis
- (2010) Nelson B. Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of Wnt canonical pathway in hematological malignancies
- (2010) Xueling GE et al. Journal of Hematology & Oncology
- Lasofoxifene in Postmenopausal Women with Osteoporosis
- (2010) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Efficacy of Bisphosphonates in the Prevention of Vertebral, Hip, and Nonvertebral-Nonhip Fractures in Osteoporosis: A Network Meta-Analysis
- (2010) Jeroen P. Jansen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
- (2010) Luigi Gennari Clinical Interventions in Aging
- Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
- (2010) Michael Lewiecki Therapeutics and Clinical Risk Management
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimal Thresholds, Linear or Nonlinear Relationships of Fracture Risk Reduction With Therapy
- (2008) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment
- (2008) Barbara M Obermayer-Pietsch et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)*
- (2008) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
- Effect of Raloxifene on Stroke and Venous Thromboembolism According to Subgroups in Postmenopausal Women at Increased Risk of Coronary Heart Disease
- (2008) Lori Mosca et al. STROKE
- Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis
- (2007) Steven Boonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More